Detalhe da pesquisa
1.
Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
Int J Clin Oncol
; 29(2): 205-212, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112832
2.
Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
Int J Urol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687165
3.
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
Int J Urol
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695571
4.
Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cells.
Int Immunol
; 34(5): 277-289, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094065
5.
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.
Int J Clin Oncol
; 28(12): 1651-1658, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658926
6.
Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
Int J Urol
; 30(12): 1112-1119, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605814
7.
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study.
Int J Urol
; 30(9): 714-721, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541136
8.
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study.
Int J Clin Oncol
; 27(1): 154-164, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800178
9.
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer.
Int J Urol
; 29(12): 1477-1487, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070138
10.
Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Int J Urol
; 29(7): 632-638, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293022
11.
Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer.
Ann Surg Oncol
; 28(9): 5349-5359, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33666810
12.
Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study.
BMC Cancer
; 21(1): 1223, 2021 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774000
13.
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.
Jpn J Clin Oncol
; 51(2): 287-295, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32893303
14.
Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.
Jpn J Clin Oncol
; 51(6): 984-991, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589927
15.
Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer.
Int J Clin Oncol
; 26(11): 2094-2103, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34357470
16.
On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma.
Int J Clin Oncol
; 26(8): 1500-1505, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34101038
17.
Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".
Qual Life Res
; 29(3): 755-763, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31583618
18.
Thiamine deficiency in a patient with recurrent renal cell carcinoma who developed weight loss with normal appetite and loss of energy soon after nivolumab treatment.
Palliat Support Care
; 18(2): 241-243, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31535612
19.
RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
Histopathology
; 75(2): 254-265, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30908700
20.
Clinical outcome of high dose rate brachytherapy with external beam radiotherapy for high-risk prostate cancer: a single institutional retrospective study.
Jpn J Clin Oncol
; 49(1): 87-91, 2019 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476164